Serum osteocalcin is significantly related to indices of obesity and lipid profile in Malaysian men

International Journal of Medical Sciences

Volumn 11, Issue 2, 2014, Pages 151-157

  Chin, Kok Yong ^a   Ima Nirwana, Soelaiman ^a   Mohamed, Isa Naina ^a   Ahmad, Fairus ^a   Mohd Ramli, Elvy Suhana ^a   Aminuddin, Amilia ^a   Wan Ngah, Wan Zurinah ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Body mass index; Cholesterol; Men; Obesity; Osteocalcin

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALAYSIA; MALE; OBESITY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

BODY MASS INDEX; CHOLESTEROL; MEN; OBESITY; OSTEOCALCIN.;

ADIPOSE TISSUE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL, HDL; HUMANS; LIPID METABOLISM; MALAYSIA; MALE; MIDDLE AGED; OBESITY; OSTEOCALCIN; WAIST CIRCUMFERENCE;

EID: 84891801688     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.7152     Document Type: Article

References (30)

1. Barrera G, Bunout D, Gattás V, de la Maza MP, Leiva L, Hirsch S. A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects. Nutrition. 2004; 20: 769-71.
2. Chin KY, Soelaiman IN, Mohamed IN, Ibrahim S, Wan Ngah WZ. The effects of age, physical activity level, and body anthropometry on calcaneal speed of sound value in men. Arch Osteoporos. 2012; 7: 135-45.
3. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: The Framingham study. J Bone Miner Res. 1993; 8: 567-73.
4. Wardlaw GM. Putting body weight and osteoporosis into perspective. Am J Clin Nutr. 1996; 63: 433S-6S.
5. Morberg CM, Tetens I, Black E, Toubro S, Soerensen TIA, Pedersen O, et al. Leptin and Bone Mineral Density: A Cross-Sectional Study in Obese and Nonobese Men. J Clin Endocrinol Metab. 2003; 88: 5795-800.
6. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000; 100: 197-207.
7. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept. 2000; 92: 73-8.
8. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci. 2008; 105: 5266-70.
9. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130: 456-69.
10. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005; 26: 97-122.
11. Kindblom JM, Ohlsson C, Ljunggren Ö, Karlsson MK, Tivesten Å, Smith U, et al. Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men. J Bone Miner Res. 2009; 24: 785-91.
12. Bae SJ, Choe JW, Chung YE, Kim BJ, Lee SH, Kim HY, et al. The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos Int. 2011; 22: 2837-46.
13. Bao Y, Zhou M, Lu Z, Li H, Wang Y, Sun L, et al. Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. Clin Endocrinol (Oxf). 2011; 75: 196-201.
14. Saleem U, Mosley TH, Kullo IJ. Serum Osteocalcin Is Associated With Measures of Insulin Resistance, Adipokine Levels, and the Presence of Metabolic Syndrome. Arterioscler Thromb Vasc Biol. 2010; 30: 1474-8.
15. Zhou M, Ma X, Li H, Pan X, Tang J, Gao Y, et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol. 2009; 161: 723-9.
16. Chin K-Y, Soelaiman I-N, Mohamed IN, Ngah WZW. Serum testosterone, sex hormone-binding globulin and total calcium levels predict the calcaneal speed of sound in men. Clinics. 2012; 67: 911-6.
17. Chin K-Y, Soelaiman I-N, Naina Mohamed I, Shahar S, Teng NIMF, Suhana Mohd Ramli E, et al. Testosterone is associated with age-related changes in bone health status, muscle strength and body composition in men. Aging Male. 2012; 15: 240-5.
18. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120: 1640-5.
19. National Cholesterol Education Program (NCEP) Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002; 106: 3143.
20. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between Serum Osteocalcin and Markers of Metabolic Phenotype. J Clin Endocrinol Metab. 2009; 94: 827-32.
21. Polgreen LE, Jacobs DR, Nathan BM, Steinberger J, Moran A, Sinaiko AR. Association of Osteocalcin With Obesity, Insulin Resistance, and Cardiovascular Risk Factors in Young Adults. Obesity. 2012; 20: 2194-201.
22. Lee SW, Jo HH, Kim MR, You YO, Kim JH. Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol Endocrinol. 2012; 28: 472-7.
23. Tan A, Gao Y, Yang X, Zhang H, Qin X, Mo L, et al. Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism. 2011; 60: 1186-92.
24. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, et al. Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2009; 94: 45-9.
25. Meilleur KG, Doumatey A, Huang H, Charles B, Chen G, Zhou J, et al. Circulating Adiponectin Is Associated with Obesity and Serum Lipids in West Africans. J Clin Endocrinol Metab. 2010; 95: 3517-21.
26. Rothenbacher D, Brenner H, März W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J. 2005; 26: 1640-6.
27. Vergès B, Petit JM, Duvillard L, Dautin G, Florentin E, Galland F, et al. Adiponectin Is an Important Determinant of ApoA-I Catabolism. Arterioscler Thromb Vasc Biol. 2006; 26: 1364-9.
28. Patti A, Gennari L, Merlotti D, Dotta F, Nuti R. Endocrine actions of osteocalcin. Int J Endocrinol. 2013; 2013: ID846480.
29. Liu JJ, Toy WC, Wong MD, Tan CS, Tavintharan S, Wong MS, et al. Elevated undercarboxylated and reduced carboxylated osteocalcin are associated with metabolic syndrome in middle age Asian females. Exp Clin Endocrinol Diabetes. 2013; 121: 329-33.
30. Pietrobelli A, Rubiano F, St-Onge MP, Heymsfield SB. New bioimpedance analysis system: improved phenotyping with whole-body analysis. Eur J Clin Nutr. 2004; 58: 1479-84.